Krystal Biotech Inc (KRYS)

Return on assets (ROA)

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Net income (ttm)	US$ in thousands	57,161	10,932	-29,812	-140,409	-135,307	-139,975	-129,729	-115,468	-103,723	-69,570	-58,147	-52,168	-42,638	-32,167	-27,141	-21,803	-20,318	-19,088	-16,486	-14,490
Total assets	US$ in thousands	853,296	818,355	790,350	684,026	531,847	558,450	576,379	601,324	616,874	626,295	451,095	443,556	443,018	310,844	311,451	318,145	205,131	209,023	214,232	205,156
ROA		6.70%	1.34%	-3.77%	-20.53%	-25.44%	-25.06%	-22.51%	-19.20%	-16.81%	-11.11%	-12.89%	-11.76%	-9.62%	-10.35%	-8.71%	-6.85%	-9.90%	-9.13%	-7.70%	-7.06%

March 31, 2024 calculation

ROA = Net income (ttm) ÷ Total assets
= $57,161K ÷ $853,296K
= 6.70%

The Return on Assets (ROA) of Krystal Biotech Inc has fluctuated over the past few quarters.

In the most recent quarter ending on March 31, 2024, the ROA was 6.70%, showing a significant improvement compared to the previous quarter at 1.34% as of December 31, 2023. This indicates that the company generated $0.067 in profit for every dollar of assets it owns.

The ROA turned negative in the third quarter of 2023 at -3.77% and continued to decline significantly in the following quarters, reaching a low of -25.44% on March 31, 2023. This suggests that the company was not efficient in generating profits from its assets during this period.

While the ROA improved between September 2022 and December 2023, it remained negative for an extended period. It is important for the company to sustain positive ROA figures to indicate healthy operational efficiency and profitability relative to the total assets employed in its business.

Overall, the trend in ROA for Krystal Biotech Inc has been volatile, with both positive and negative fluctuations. Monitoring this ratio over time can provide insights into the company's operational efficiency and effectiveness in generating profits from its assets.